Search Within

Alexander Edward Drilon

Formats
  1. Meeting Abstract (374)
  2. Journal Article (224)
  3. Review (23)
  4. Editorial (6)
  5. Correspondence (3)
  6. Book Section (2)
  7. Research Letter (2)
  8. Book Whole (1)
  9. Guidelines (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (637)
  2. Solid Tumor Oncology Division (637)
  3. Thoracic Oncology (637)
  4. Department of Pathology and Laboratory Medicine (208)
  5. GSK Faculty (189)
  6. Human Oncology and Pathogenesis Program (158)

More Groups

People
  1. Marc Ladanyi (122)
  2. Mark Kris (90)
  3. Maria Arcila (82)
  4. David Hyman (78)
  5. Bob Li (65)
  6. Charles Rudin (64)

More People

Years
  1. 2025 (21)
  2. 2024 (61)
  3. 2023 (68)
  4. 2022 (85)
  5. 2021 (76)
  6. 2020 (81)

More Years

Publications
  1. Journal of Clinical Oncology (138)
  2. Annals of Oncology (94)
  3. Journal of Thoracic Oncology (85)
  4. Clinical Cancer Research (31)
  5. JCO Precision Oncology (24)
  6. Cancer Research (23)

More Publications

Publishers
  1. American Society of Clinical Oncology (164)
  2. Elsevier Inc. (119)
  3. Oxford University Press (113)
  4. American Association for Cancer Research (78)
  5. Nature Publishing Group (27)
  6. S. Karger AG (23)

More Publishers

Results (637)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety with selpercatinib by last prior systemic therapy received in patients (Pts) with RET fusion + non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Gautschi, O.; Drilon, A.; Tan, D. S. W.; Oxnard, G. R.; McCoach, C.; Goto, K.; Park, K.; Alonso Casal, G.; de Braud, F.; French, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Mazieres, J.; Tomasini, P.; Lusque, A.; Boucekine, M.; Gautschi, O.; Cortot, A. B.; Couraud, S.; Thai, A.; Ng, T.; Greillier, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer
    Meeting Abstract

    Leyvraz, S.; Yang, J. C. H.; Casali, P. G.; Castro, G.; Kim, E. S.; Lassen, U. N.; Lopez-Rios, F.; Penault-Llorca, F.; Pappo, A.; Rudzinski, E. R.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients
    Meeting Abstract

    Italiano, A.; Hong, D. S.; Briggs, A.; Garcia-Foncillas, J.; Lassen, U. N.; Vassal, G.; Kummar, S.; van Tilburg, C. M.; Keating, K.; Reeves, J. A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in NTRK fusion-positive NSCLC: Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
    Meeting Abstract

    Drilon, A.; Paz-Ares, L.; Doebele, R. C.; Farago, A. F.; Liu, S. V.; Chawla, S. P.; Tosi, D.; Blakely, C. M.; Krauss, J. C.; Bazhenova, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) from patients (Pts) with NTRK fusion-positive (NTRK-fp) solid tumours receiving entrectinib in the global phase II STARTRK-2 study
    Meeting Abstract

    Conley, A. P.; Demetri, G. D.; Doebele, R. C.; Drilon, A.; Paz-Ares, L.; Cassier, P.; Siena, S.; Ahn, M. J.; Buchschacher, G. L. Jr; Seto, T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy
    Meeting Abstract

    Liu, S. V.; De Braud, F.; Drilon, A.; Doebele, R. C.; Patel, M. R.; Cho, B. C.; Ahn, M. J.; Chiu, C. H.; Farago, A. F.; Goto, K.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Intracranial efficacy of entrectinib in patients with NTRK fusion-positive solid tumours and baseline CNS metastases
    Meeting Abstract

    John, T.; Chiu, C. H.; Cho, B. C.; Fakih, M.; Farago, A. F.; Demetri, G. D.; Goto, K.; Doebele, R. C.; Siena, S.; Drilon, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Clinical implications of drug-induced liver injury in early-phase oncology clinical trials
    Journal Article

    Mondaca, S. P.; Liu, D.; Flynn, J. R.; Badson, S.; Hamaway, S.; Gounder, M. M.; Khalil, D. N.; Drilon, A. E.; Li, B. T.; Jhaveri, K. L.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • The METeoric rise of MET in lung cancer
    Review

    Friedlaender, A.; Drilon, A.; Banna, G. L.; Peters, S.; Addeo, A.
    Cancer (2020)

    Fulltext@MSK | Save